Genetic services for familial cancer patients: A survey of national cancer institute cancer centers

Julie A. Thompson, Thomas A. Sellers, Celine M Vachon, Mary Ahrens, Mary Sumpmann, John Kersey, Georgia L. Wiesner, John D. Potter

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

In the past d3ecade, significant progress has been made in understanding the genetic component of familial cancers.Genes associated with familial colon and breast cancers have recently been isolated and molecular diagnostic tests are expected to become available in the near future. Clinicians now have the opportunity to recognize and counsel individuals with elevated risk of cancer by identifying risk factors and genes associated with cancer predisposition. The rapid advances in molecular technology are a direct challenge to the medical community and cancer centers to supply specialized clinical services for familial cancers. We sought to ascertain the activities of cancer centers in the development of programs and the provision of genetic services for familial cancer. We surveyed 41 centers with National Cancer Institute (NCI) cancer center support grants. One half of the centers responding (17 of 34) reported that they provide some genetic services for familial cancer. About one half of these 17 centers (eight [57%] of 14; the three remaining clinics that responded had incomplete information on this indicator) see a variety of patient types on a small scale (fewer than 100 patients per year), and most provide four basic clinical evaluations: medical evaluation, cancer risk assessment, genetic counseling, and pedigree analysis. Staffing of each center varied widely, as did the types of screening services offered (including molecular diagnostic testing). Several centers (six [35%] of 17) indicated that they were in the developmental stages for serving familial cancer patients, and many seem to be increasing their activities in this area. The remaining 17 NCI-supported centers that responded, however, currently provide no genetic services for familial cancers. The results of this survey suggest that there is interest in developing clinical programs for familial cancers by NCI-supported cancer centers, but most of these programs are in developmental stages. A base line has been established to monitor future progress for the provision of cancer genetic services. [J Natl Cancer Inst 1995; 87:1446-55].

Original languageEnglish (US)
Pages (from-to)1446-1455
Number of pages10
JournalJournal of the National Cancer Institute
Volume87
Issue number19
DOIs
StatePublished - Apr 4 1995
Externally publishedYes

Fingerprint

Genetic Services
National Cancer Institute (U.S.)
Cancer
Genes
Risk assessment
Neoplasms
Screening
Testing
Surveys and Questionnaires
Molecular Diagnostic Techniques
Program Development
Molecular Pathology
Organized Financing
Gene

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Radiology Nuclear Medicine and imaging
  • Oncology
  • Cancer Research

Cite this

Genetic services for familial cancer patients : A survey of national cancer institute cancer centers. / Thompson, Julie A.; Sellers, Thomas A.; Vachon, Celine M; Ahrens, Mary; Sumpmann, Mary; Kersey, John; Wiesner, Georgia L.; Potter, John D.

In: Journal of the National Cancer Institute, Vol. 87, No. 19, 04.04.1995, p. 1446-1455.

Research output: Contribution to journalArticle

Thompson, JA, Sellers, TA, Vachon, CM, Ahrens, M, Sumpmann, M, Kersey, J, Wiesner, GL & Potter, JD 1995, 'Genetic services for familial cancer patients: A survey of national cancer institute cancer centers', Journal of the National Cancer Institute, vol. 87, no. 19, pp. 1446-1455. https://doi.org/10.1093/jnci/87.19.1446
Thompson, Julie A. ; Sellers, Thomas A. ; Vachon, Celine M ; Ahrens, Mary ; Sumpmann, Mary ; Kersey, John ; Wiesner, Georgia L. ; Potter, John D. / Genetic services for familial cancer patients : A survey of national cancer institute cancer centers. In: Journal of the National Cancer Institute. 1995 ; Vol. 87, No. 19. pp. 1446-1455.
@article{5fb5a9883c8e40d88f880c6e337b37c3,
title = "Genetic services for familial cancer patients: A survey of national cancer institute cancer centers",
abstract = "In the past d3ecade, significant progress has been made in understanding the genetic component of familial cancers.Genes associated with familial colon and breast cancers have recently been isolated and molecular diagnostic tests are expected to become available in the near future. Clinicians now have the opportunity to recognize and counsel individuals with elevated risk of cancer by identifying risk factors and genes associated with cancer predisposition. The rapid advances in molecular technology are a direct challenge to the medical community and cancer centers to supply specialized clinical services for familial cancers. We sought to ascertain the activities of cancer centers in the development of programs and the provision of genetic services for familial cancer. We surveyed 41 centers with National Cancer Institute (NCI) cancer center support grants. One half of the centers responding (17 of 34) reported that they provide some genetic services for familial cancer. About one half of these 17 centers (eight [57{\%}] of 14; the three remaining clinics that responded had incomplete information on this indicator) see a variety of patient types on a small scale (fewer than 100 patients per year), and most provide four basic clinical evaluations: medical evaluation, cancer risk assessment, genetic counseling, and pedigree analysis. Staffing of each center varied widely, as did the types of screening services offered (including molecular diagnostic testing). Several centers (six [35{\%}] of 17) indicated that they were in the developmental stages for serving familial cancer patients, and many seem to be increasing their activities in this area. The remaining 17 NCI-supported centers that responded, however, currently provide no genetic services for familial cancers. The results of this survey suggest that there is interest in developing clinical programs for familial cancers by NCI-supported cancer centers, but most of these programs are in developmental stages. A base line has been established to monitor future progress for the provision of cancer genetic services. [J Natl Cancer Inst 1995; 87:1446-55].",
author = "Thompson, {Julie A.} and Sellers, {Thomas A.} and Vachon, {Celine M} and Mary Ahrens and Mary Sumpmann and John Kersey and Wiesner, {Georgia L.} and Potter, {John D.}",
year = "1995",
month = "4",
day = "4",
doi = "10.1093/jnci/87.19.1446",
language = "English (US)",
volume = "87",
pages = "1446--1455",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "19",

}

TY - JOUR

T1 - Genetic services for familial cancer patients

T2 - A survey of national cancer institute cancer centers

AU - Thompson, Julie A.

AU - Sellers, Thomas A.

AU - Vachon, Celine M

AU - Ahrens, Mary

AU - Sumpmann, Mary

AU - Kersey, John

AU - Wiesner, Georgia L.

AU - Potter, John D.

PY - 1995/4/4

Y1 - 1995/4/4

N2 - In the past d3ecade, significant progress has been made in understanding the genetic component of familial cancers.Genes associated with familial colon and breast cancers have recently been isolated and molecular diagnostic tests are expected to become available in the near future. Clinicians now have the opportunity to recognize and counsel individuals with elevated risk of cancer by identifying risk factors and genes associated with cancer predisposition. The rapid advances in molecular technology are a direct challenge to the medical community and cancer centers to supply specialized clinical services for familial cancers. We sought to ascertain the activities of cancer centers in the development of programs and the provision of genetic services for familial cancer. We surveyed 41 centers with National Cancer Institute (NCI) cancer center support grants. One half of the centers responding (17 of 34) reported that they provide some genetic services for familial cancer. About one half of these 17 centers (eight [57%] of 14; the three remaining clinics that responded had incomplete information on this indicator) see a variety of patient types on a small scale (fewer than 100 patients per year), and most provide four basic clinical evaluations: medical evaluation, cancer risk assessment, genetic counseling, and pedigree analysis. Staffing of each center varied widely, as did the types of screening services offered (including molecular diagnostic testing). Several centers (six [35%] of 17) indicated that they were in the developmental stages for serving familial cancer patients, and many seem to be increasing their activities in this area. The remaining 17 NCI-supported centers that responded, however, currently provide no genetic services for familial cancers. The results of this survey suggest that there is interest in developing clinical programs for familial cancers by NCI-supported cancer centers, but most of these programs are in developmental stages. A base line has been established to monitor future progress for the provision of cancer genetic services. [J Natl Cancer Inst 1995; 87:1446-55].

AB - In the past d3ecade, significant progress has been made in understanding the genetic component of familial cancers.Genes associated with familial colon and breast cancers have recently been isolated and molecular diagnostic tests are expected to become available in the near future. Clinicians now have the opportunity to recognize and counsel individuals with elevated risk of cancer by identifying risk factors and genes associated with cancer predisposition. The rapid advances in molecular technology are a direct challenge to the medical community and cancer centers to supply specialized clinical services for familial cancers. We sought to ascertain the activities of cancer centers in the development of programs and the provision of genetic services for familial cancer. We surveyed 41 centers with National Cancer Institute (NCI) cancer center support grants. One half of the centers responding (17 of 34) reported that they provide some genetic services for familial cancer. About one half of these 17 centers (eight [57%] of 14; the three remaining clinics that responded had incomplete information on this indicator) see a variety of patient types on a small scale (fewer than 100 patients per year), and most provide four basic clinical evaluations: medical evaluation, cancer risk assessment, genetic counseling, and pedigree analysis. Staffing of each center varied widely, as did the types of screening services offered (including molecular diagnostic testing). Several centers (six [35%] of 17) indicated that they were in the developmental stages for serving familial cancer patients, and many seem to be increasing their activities in this area. The remaining 17 NCI-supported centers that responded, however, currently provide no genetic services for familial cancers. The results of this survey suggest that there is interest in developing clinical programs for familial cancers by NCI-supported cancer centers, but most of these programs are in developmental stages. A base line has been established to monitor future progress for the provision of cancer genetic services. [J Natl Cancer Inst 1995; 87:1446-55].

UR - http://www.scopus.com/inward/record.url?scp=0029120584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029120584&partnerID=8YFLogxK

U2 - 10.1093/jnci/87.19.1446

DO - 10.1093/jnci/87.19.1446

M3 - Article

C2 - 7674332

AN - SCOPUS:0029120584

VL - 87

SP - 1446

EP - 1455

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 19

ER -